Get started
Author

Maurie Markman

Observed names: M Markman, M. Markman
Institution: Cleveland Clinic
OpenAlex ID: A5110182324
Paclitaxel in cancer therapy
2002 · Maurie Markman, Tarek M Mekhail · Expert Opinion on Pharmacotherapy · 377
Cancer Chemotherapeutic Agents
1996 · Geza T. Terezhalmy, Christopher C. Whitmyer, et al. · Dental Clinics of North America · 273
Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma
1992 · Thomas B. Hakes, Eva Chalas, et al. · Gynecologic Oncology · 162
Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease.
1992 · M Markman, T Hakes, et al. · Journal of Clinical Oncology · 130
Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma
1989 · William J. Hoskins, Stephen C. Rubin, et al. · Gynecologic Oncology · 117
Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer
1989 · Stephen C. Rubin, William J. Hoskins, et al. · American Journal of Obstetrics and Gynecology · 104
Follow-up of Memorial Sloan-Kettering Cancer Center patients treated on National Cancer Institute Treatment Referral Center protocol 9103: paclitaxel in refractory ovarian cancer.
1996 · M Markman, T Hakes, et al. · Journal of Clinical Oncology · 50
Survival Probability in Ovarian Clear Cell Adenocarcinoma
1999 · Alexander W. Kennedy, Maurie Markman, et al. · Gynecologic Oncology · 43
Persistent hypomagnesemia following cisplatin chemotherapy in patients with ovarian cancer
1991 · Maurie Markman, Robert Rothman, et al. · Journal of Cancer Research and Clinical Oncology · 40
Expression of P-glycoprotein in epithelial ovarian cancer: Evaluation as a marker of multidrug resistance
1990 · Stephen C. Rubin, Connie L. Finstad, et al. · American Journal of Obstetrics and Gynecology · 37
Neurotoxicity associated with a regimen of carboplatin (AUC 5-6) and paclitaxel (175 mg/m 2 over 3 h) employed in the treatment of gynecologic malignancies
2001 · Maurie Markman, Alexander Kennedy, et al. · Journal of Cancer Research and Clinical Oncology · 36
Safety and Efficacy of Adjuvant Single-Agent Ifosfamide in Uterine Sarcoma
2000 · David M. Kushner, Kenneth D. Webster, et al. · Gynecologic Oncology · 28
High-Intensity Intravenous Cyclophosphamide and Cisplatin, Interim Surgical Debulking, and Intraperitoneal Cisplatin in Advanced Ovarian Carcinoma: A Pilot Trial with Ten-Year Follow-up
1997 · Fred Shapiro, Jeffrey Schneider, et al. · Gynecologic Oncology · 27
Intensive alternating chemotherapy regimen in small cell carcinoma of the lung.
1985 · M Markman, M D Abeloff, et al. · PubMed · 23
Long-term access to the peritoneal cavity in ovarian cancer patients
1989 · Stephen C. Rubin, William J. Hoskins, et al. · Gynecologic Oncology · 21
Ip chemotherapy employing a regimen of cisplatin, cytarabine, and bleomycin.
1986 · M Markman, S Cleary, et al. · PubMed · 15
Declining CA-125 in an Ovarian Cancer Patient with Progression of Measurable Disease: A Rational Hypothesis for Discordant Results
2000 · Maurie Markman, Alexander Kennedy, et al. · Gynecologic Oncology · 11
Intraperitoneal taxol
1996 · Maurie Markman · Cancer treatment and research · 10
Salvage intraperitoneal therapy of small-volume residual ovarian cancer: impact of pretreatment finding of peritoneal carcinomatosis on the surgical complete response rate
1992 · Maurie Markman, Bonnie Reichman, et al. · Journal of Cancer Research and Clinical Oncology · 10
A phase II trial of PALA+dipyridamole in patients with advanced soft-tissue sarcoma
1991 · Ephraim S. Casper, Jose Baselga, et al. · Cancer Chemotherapy and Pharmacology · 10
Intraperitoneal chemotherapy for ovarian carcinoma
1985 · Maurie Markman, Stephen B. Howell · Cancer treatment and research · 9
Phase I Trial of Intravenous and Intraperitoneal Administration of Granulocyte-Macrophage Colony-Stimulting Factor
1994 · Guy C. Toner, Janice L. Gabrilove, et al. · Journal of Immunotherapy · 8
The Antiemetic Efficacy of Oral Ondansetron plus Intravenous Dexamethasone in Patients with Gynecologic Malignancies Receiving Carboplatin-Based Chemotherapy
2000 · Maurie Markman, Alexander Kennedy, et al. · Gynecologic Oncology · 7
Second‐line chemotherapy for refractory cancer: Intraperitoneal chemotherapy
1994 · Maurie Markman · Seminars in Surgical Oncology · 7
Late effects of cisplatin-based chemotherapy on renal function in patients with ovarian carcinoma
1991 · Maurie Markman, Robert Rothman, et al. · Gynecologic Oncology · 7
Works count: 33
Citation count: 1,580
H-index: 15
I10-index: 20
Year
Topic
Type